Open Orphan - Investment Case
ORPH Thu, 10 Oct 2019, 07:00am BST
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland
What is Open Orphan's strategy? Why is it so attractive to shareholders? Cathal Friel provides a short summary of the investment proposition.